Skip to search formSkip to main contentSkip to account menu

Guanabenz Acetate

Known as: Guanabenz Monoacetate, Acetate, Guanabenz, 3-((2,6-Dichlorophenyl)methylene)carbazamidine Monoacetate 
The orally bioavailable, acetate salt form of guanabenz, a centrally-acting alpha-2 adrenergic receptor agonist, with anti-hypertensive and potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The Great Barrier Reef sponge Luffariella variabilis (Poléjaeff 1884) produces a range of potent anti-inflammatory compounds as… 
2003
2003
Cytotoxicity-guided fractionation of the alcohol extract of the brown alga, Cystoseira myrica, afforded four new cytotoxic… 
Highly Cited
1999
Highly Cited
1999
In Dahl salt-sensitive rats on a high salt diet or normotensive rats with chronic central infusion of sodium, increased brain… 
1996
1996
The effects of blockade of brain "ouabain" by central infusion of antibody Fab fragments, which bind ouabain and brain "ouabain… 
1994
1994
Four new metabolites (1-4) were isolated from mycelium of Aspergillus terreus IFO 6123 producing asterriquinone (ARQ). The… 
1984
1984
Abundant evidence exists for the cumulative adverse effects of hypertension and hypercholesterolemia on the progression of… 
1984
1984
Guanabenz Acetate (GA) is a new long-lasting alpha-two agonist. We found that it effectively suppressed opioid withdrawal in the… 
1983
1983
Guanabenz acetate is a new centrally acting alpha 2-adrenergic agonist. Seventeen hypertensive men, in whom BP was normalized… 
1981
1981
A potent tumour promoter on mouse skin, phorbol-9-myristate-9a-acetate, induces certain clones of Friend erythroleukemia cells to…